Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Adverse Impact of Desulfovibrio Spp. and Beneficial Role of Anaerostipes Spp. on Renal Function: Insights From a Mendelian Randomization Analysis Publisher Pubmed



Mazidi M1 ; Shekoohi N2 ; Covic A3 ; Mikhailidis DP4 ; Banach M5, 6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Twin Research and Genetic Epidemiology, King’s College London, St Thomas’ Hospital, Strand, London, SE1 7EH, United Kingdom
  2. 2. Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, 14155-6446, Iran
  3. 3. Nephrology Clinic, Dialysis and Renal Transplant Center, ‘C.I. PARHON’ University Hospital, ‘Grigore T. Popa’ University of Medicine, Iasi, 700469, Romania
  4. 4. Department of Clinical Biochemistry, Royal Free Campus, University College London, Medical School, University College London (UCL), London, NW3 2QG, United Kingdom
  5. 5. Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz, 93-338, Poland
  6. 6. Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, 93-338, Poland
  7. 7. Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, 65-046, Poland

Source: Nutrients Published:2020


Abstract

Background: The microbiota composition is now considered as one of the main modifiable risk factors for health. No controlled study has been performed on the association between microbiota composition and renal function. We applied Mendelian randomization (MR) to estimate the casual impact of eight microbiota genera on renal function and the risk of chronic kidney disease (CKD). Methods: MR was implemented by using summary-level data from the largest-ever genome-wide association studies (GWAS) conducted on microbiota genera, CKD and renal function parameters. The inverse-variance weighted method (IVW), weighted median (WM)-based method, MR-Egger, MR-Robust Adjusted Profile Score (RAPS), MR-Pleiotropy RESidual Sum and Outlier (PRESSO) were applied. A sensitivity analysis was conducted using the leave-one-out method. Results: The Anaerostipes genus was associated with higher estimated glomerular filtration rate (eGFR) in the overall population (IVW: β = 0.003, p = 0.021) and non-diabetes mellitus (DM) subgroup (IVW: β = 0.003, p = 0.033), while it had a non-significant association with the risk of CKD and eGFR in DM patients. Subjects with higher abundance of Desulfovibrio spp. had a significantly lower level of eGFR (IVW: β = −0.001, p = 0.035); the same results were observed in non-DM (IVW: β = −0.001, p = 0.007) subjects. Acidaminococcus, Bacteroides, Bifidobacterium, Faecalibacterium, Lactobacillus and Megamonas had no significant association with eGFR in the overall population, DM and non-DM subgroups (IVW: p > 0.105 for all groups); they also presented no significant association with the risk of CKD (IVW: p < 0.201 for all groups). Analyses of MR-PRESSO did not highlight any outlier. The pleiotropy test, with very negligible intercept and insignificant p-value, also indicated no chance of pleiotropy for all estimations. The leave-one-out method demonstrated that the observed links were not driven by single single-nucleotide polymorphism. Conclusions: Our results suggest an adverse association of Desulfovibrio spp. and a beneficial association of Anaerostipes spp. with eGFR. Further studies using multiple robust instruments are needed to confirm these results. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Other Related Docs
9. Inspection of Heritable Gut Microbiota Roles in Obesity, Journal of Biological Regulators and Homeostatic Agents (2023)
15. Gut Microbiota and Covid-19: A Systematic Review, Health Science Reports (2023)
19. Spondyloarthropathies and Gut Microbiota, Ankylosing Spondylitis - Axial Spondyloarthritis: Cellular# Molecular and Environmental Factors (2021)
20. Gut Microbiota Might Act As a Potential Therapeutic Pathway in Covid-19, Current Pharmaceutical Biotechnology (2022)
21. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer, International Archives of Allergy and Immunology (2022)